Regen BioPharma Inc (RGBP)

[SidVicious]

It isn't Regen's DCellVax as I have stated over and over.
1. There are many "like" vaccines. This one isn't targeting the indolamine 2,3 deoxygenase (IDO) pathway.

2.Lead investigator Joseph Baar has no connection to Regen or anyone associated with the company from what I can see. He consults for AMGEN or has in the past.

http://www.uhhospitals.org/find-a-doctor/baar-joseph-12738

3.The trial includes a drug from Lilly to see if the vaccine works with the drug.

4. AGain, it's not Regen as DCELLVAX has not yet been approved for P1 trials. The FDA, I repeat, the FDA doesn't grant trials to anything UNTIL IND is approved!

Conclusion

Based on flimsy DD, yet again, this isn't a trial involving anything to do with REGEN. It's not hard to see that there is no connection based on the facts!

Oh, the stock is still tanking. Going down every day. Drip drip drip.